Drug Discrimination in Methadone-Maintained Humans Study 1
Completed
University of Arkansas
Phase 1
2006-09-01
This study involves giving psychoactive drugs intramuscularly (injected into the muscle of
the upper arm or the hip) and/or orally, and measuring the subject's ability to tell the
difference between one drug and another, as well as measuring the effects of the drugs on
mood, physiology (e.g., heart rate, blood pressure, respiration rate) and behavior. Each
subject will receive 2-4 of the listed interventions.
Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson Disease
Completed
Michael J. Fox Foundation for Parkinson's Research
Phase 2
2009-07-01
The primary purpose of this study is to establish a dosage of isradipine CR that is tolerable
and demonstrates preliminary efficacy for utilization in future pivotal efficacy studies.
Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson Disease
Completed
Northwestern University Dixon Fund
Phase 2
2009-07-01
The primary purpose of this study is to establish a dosage of isradipine CR that is tolerable
and demonstrates preliminary efficacy for utilization in future pivotal efficacy studies.
Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson Disease
Completed
The Parkinson Study Group
Phase 2
2009-07-01
The primary purpose of this study is to establish a dosage of isradipine CR that is tolerable
and demonstrates preliminary efficacy for utilization in future pivotal efficacy studies.
Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson Disease
Completed
Northwestern University
Phase 2
2009-07-01
The primary purpose of this study is to establish a dosage of isradipine CR that is tolerable
and demonstrates preliminary efficacy for utilization in future pivotal efficacy studies.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
